Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haoxi Health Technology (HAO) Receivables (2023 - 2025)

Haoxi Health Technology has reported Receivables over the past 3 years, most recently at $729196.0 for Q2 2025.

  • Quarterly results put Receivables at $729196.0 for Q2 2025, up 48.76% from a year ago — trailing twelve months through Jun 2025 was $729196.0 (up 48.76% YoY), and the annual figure for FY2025 was $729196.0, up 48.76%.
  • Receivables for Q2 2025 was $729196.0 at Haoxi Health Technology, up from $490192.0 in the prior quarter.
  • Over the last five years, Receivables for HAO hit a ceiling of $729196.0 in Q2 2025 and a floor of $7748.0 in Q2 2023.
  • Median Receivables over the past 3 years was $490192.0 (2024), compared with a mean of $409045.3.
  • Biggest five-year swings in Receivables: skyrocketed 6226.69% in 2024 and later soared 48.76% in 2025.
  • Haoxi Health Technology's Receivables stood at $7748.0 in 2023, then skyrocketed by 6226.69% to $490192.0 in 2024, then skyrocketed by 48.76% to $729196.0 in 2025.
  • The last three reported values for Receivables were $729196.0 (Q2 2025), $490192.0 (Q2 2024), and $7748.0 (Q2 2023) per Business Quant data.